Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.

Pookot D, Li LC, Tabatabai ZL, Tanaka Y, Greene KL, Dahiya R.

J Urol. 2006 Aug;176(2):793-6. Erratum in: J Urol. 2006 Oct;176(4 Pt 1):1688.

PMID:
16813949
2.

Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.

Goto T, Nakano M, Ito S, Ehara H, Yamamoto N, Deguchi T.

Urology. 2007 Jul;70(1):127-30.

PMID:
17656222
3.
4.

Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men.

Hernández J, Balic I, Johnson-Pais TL, Higgins BA, Torkko KC, Thompson IM, Leach RJ.

J Urol. 2006 Feb;175(2):523-7.

PMID:
16406987
5.

IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.

Schildkraut JM, Demark-Wahnefried W, Wenham RM, Grubber J, Jeffreys AS, Grambow SC, Marks JR, Moorman PG, Hoyo C, Ali S, Walther PJ.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):403-8.

6.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
7.

Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk.

Singal R, Das PM, Manoharan M, Reis IM, Schlesselman JJ.

Oncol Rep. 2005 Aug;14(2):569-73.

PMID:
16012746
8.

Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.

Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ.

J Urol. 2002 Nov;168(5):2245-8.

PMID:
12394768
9.

Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans.

Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY.

J Urol. 2006 Jan;175(1):108-12; discussion 112.

PMID:
16406883
10.

Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.

Beuten J, Garcia D, Brand TC, He X, Balic I, Canby-Hagino E, Troyer DA, Baillargeon J, Hernandez J, Thompson IM, Leach RJ, Naylor SL.

J Urol. 2009 Oct;182(4):1614-20. doi: 10.1016/j.juro.2009.06.016. Epub 2009 Aug 15.

PMID:
19683737
11.

Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.

Bangsi D, Zhou J, Sun Y, Patel NP, Darga LL, Heilbrun LK, Powell IJ, Severson RK, Everson RB.

Urol Oncol. 2006 Jan-Feb;24(1):21-7.

PMID:
16414488
12.

Association of polymorphisms in TGFB1 and prostate cancer prognosis.

Brand TC, Bermejo C, Canby-Hagino E, Troyer DA, Baillargeon J, Thompson IM, Leach RJ, Naylor SL.

J Urol. 2008 Feb;179(2):754-8. Epub 2007 Dec 20.

PMID:
18082198
13.

Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites.

Woodson K, Hayes R, Wideroff L, Villaruz L, Tangrea J.

Prostate. 2003 May 15;55(3):199-205.

PMID:
12692786
14.

Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.

Wang L, Habuchi T, Tsuchiya N, Mitsumori K, Ohyama C, Sato K, Kinoshita H, Kamoto T, Nakamura A, Ogawa O, Kato T.

Cancer Res. 2003 Aug 1;63(15):4407-11.

15.

Association of prostate cancer with vitamin D receptor gene polymorphism.

Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA.

Cancer Res. 1996 Sep 15;56(18):4108-10.

16.

CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy.

Powell IJ, Zhou J, Sun Y, Sakr WA, Patel NP, Heilbrun LK, Everson RB.

J Urol. 2004 Nov;172(5 Pt 1):1848-52.

PMID:
15540736
17.

E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.

Bonilla C, Mason T, Long L, Ahaghotu C, Chen W, Zhao A, Coulibaly A, Bennett F, Aiken W, Tullock T, Coard K, Freeman V, Kittles RA.

Prostate. 2006 Apr 1;66(5):546-56.

PMID:
16372334
18.

A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.

Ben Nasr H, Hamrita B, Batbout M, Gabbouj S, Bouaouina N, Chouchane L, Chahed K.

Clin Chim Acta. 2010 Sep 6;411(17-18):1253-7. doi: 10.1016/j.cca.2010.05.001. Epub 2010 May 9.

PMID:
20462505
19.

Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.

Medina-Franco H, Ramos-De la Medina A, Vizcaino G, Medina-Franco JL.

Ann Surg Oncol. 2007 Aug;14(8):2246-9. Epub 2007 Jun 5.

PMID:
17549573
20.

Association of the -160 C --> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk.

Wu MS, Huang SP, Chang YT, Lin MT, Shun CT, Chang MC, Wang HP, Chen CJ, Lin JT.

Cancer. 2002 Mar 1;94(5):1443-8.

Supplemental Content

Support Center